Ledger.Open graph →
SEC Form D · filed May 20, 2020

Nivagen Pharmaceuticals, Inc

Offering
$16.0M
Sold
$16.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SACRAMENTO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Rob C. Hart · San Francisco, CADirectorAshish C. Sevak · Paramus, NJDirectorJaswinder Matharu · Douglas, Isle of Man, United KingdomDirectorDapeng Xu · New York, NYDirectorRichard Cohan · Greenville, INDirectorBikramjit Singh · Morganville, NJDirectorJwalant Shukla · Sacramento, CAExec · DirectorGarth Ebanks · Grand Cayman, Cayman IslandsDirectorCliff R. Brokaw · CHEVY CHASE, MDDirectorJaswinder Matharu · Douglas, Isle of Man, United KingdomDirectorBikramjit Singh · Morganville, NJDirectorJwalant Shukla · Sacramento, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗